Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer's Disease on April 12, 2024 -April 01, 2024 at 07:31 am EDT
NEW YORK, April 01, 2024 -- Cognition Therapeutics, Inc. , a clinical stage company developing drugs that treat neurodegenerative disorders, today announced it will host a virtual KOL event on...